Navigation Links
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from Blindness
Date:5/14/2013

MENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients the Avellino-GENE Detection System (AGDS™) Test that makes LASIK safer. Prior to undergoing refractive surgery such as LASIK, the AGDS Test detects, with 100 percent accuracy, the ACD genetic mutation in which carriers are at an extremely high risk of experiencing eventual blindness as a result of vision-correction refractive surgery. NVISION Laser Eye Centers now offer Avellino Lab USA's AGDS Test at 10 of its 17 locations throughout California.

(Logo: http://photos.prnewswire.com/prnh/20130514/SF12152LOGO)

The AGDS Test is the world's first genetic test to detect ACD, a disease that causes cloudiness, specifically grey-white granular deposits on the corneas, which can lead to complete loss of sight. While ACD usually develops slowly, carriers of this genetic mutation are at an extremely high risk of experiencing diminished vision and eventual blindness should they undergo vision-correction refractive surgery such as LASIK, LASEK or PRK. Fortunately, the AGDS Test positively identifies with 100 percent accuracy if a person has the genetic mutation. By doing so, the test reduces the risk of patients with ACD having post-LASIK vision impairment or blindness and increases their confidence that they are avoiding unnecessary harm to their vision. 

"We pride ourselves in offering our patients the latest technologies to make vision correction surgery even safer for our patients," said Dr. Tom Tooma , founder of NVISION Laser Eye Centers. "Offering the AGDS Test differentiates NVISION by adding a level of safety to the LASIK procedure that other laser eye centers cannot offer. We are very excited to be the first provider in the country and the only one in southern California to offer the AGDS Test."

The AGDS Test is easy and safe, involving just a simple mouth swab from a patient's cheek. The sample is then sent to Avellino Lab USA's certified molecular diagnostic testing lab. Within 24 to 48 hours, the results are provided to the NVISION physician to share with the patient. Based on a negative result, patients are able to proceed with the planned LASIK procedure with confidence. If an individual is identified as positive for the genetic mutation, he or she will be advised against having LASIK surgery and encouraged to take protective measures, such as minimizing exposure to UV light by wearing appropriate protective lenses, to help postpone the progression of ACD symptoms.

"NVISION's offering of the AGDS Test demonstrates their commitment to providing patients with the most innovative and state-of-the-art care," said Scott Korney , chief operating officer of Avellino Lab USA. "We are proud to work with NVISION in advancing our efforts to make LASIK safer for the thousands of patients who undergo eye vision correction surgery each year."

About Avellino Lab USA
Avellino Lab USA has developed the first and only commercially available testing system for Avellino Corneal Dystrophy (ACD), also known as Granular Corneal Dystrophy type 2. The company's advanced genetic diagnostics system provides fast, safe and affordable evaluations of an individual's genetic predisposition to ACD. Known as the Avellino-GENE Detection System (AGDS™) Test, Avellino Lab USA is able to positively identify, with 100 percent accuracy, a patient's ACD status. Based on the test's results, patients and their physician can make an informed decision when considering vision correction surgery.

About NVISION Laser Eye Centers
NVISION Laser Eye Centers now has 17 locations throughout California. NVISION Laser Eye Centers is the first provider in California to offer LASIK eye surgery with the Swiss-engineered Ziemer Femto LDVD Crystal Line™ Laser -- the highest level of laser vision correction available today. NVISION is also the first provider in California to offer the bladeless, computer-controlled LenSx laser, unquestionably the most technologically advanced option for laser cataract surgery.

With more than 1,400 eye doctors who refer their patients and trust their own eyes to NVISION surgeons, NVISION Laser Eye Centers is the Eye Doctors' #1 Choice.

For more information, call 1-877-91NVISION (1-877-916-8474).


'/>"/>
SOURCE Avellino Lab USA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Envisioning the Future: Hospitals Fully Integrated with Medical Device Connectivity Solutions
2. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
3. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
4. Block Engineering Partners with SKAE and Pembroke for Quantum Cascade Laser Instrument Sales
5. Surgeon-Operated Palm Beach Tattoo Removal Clinic Incorporates Astanza Duality Laser Technology
6. Dr. TATTOFF Announces Use of Astanza Laser Tattoo Removal Systems for New Phoenix Location
7. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
8. Pinnacle Biologics acquires PDT laser technology
9. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
10. Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
11. Cogmedix Expands To Support Laser Based Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... June 27, 2017 , ... Children’s National Health System ... rankings, with its Neonatology program ranking #1 out of more than 1500 neonatal ... to the coveted Honor Roll, a distinction given to the top performing children’s hospitals ...
(Date:6/26/2017)... MD. (PRWEB) , ... June 26, 2017 , ... ... crop, according to a recent review of government data released by the United ... improvement in management practices, Maryland’s soybean farmers have increased their productivity on less ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with missing teeth ... with or without a referral. Dr. Cotey is a trusted dentist who has placed ... replacement option. , Patients with missing teeth in Fitchburg, WI, are encouraged to find ...
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root NPI ... This is a new, greatly improved version of the Doctor Referral teaming dataset commonly ... Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by Medicare ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
Breaking Medicine News(10 mins):